Authors: | Strosberg, J.; Zemla, T.; Geyer, S.; Pulsipher, S.; Behr, S.; Raj, N.; Vijayvergia, N.; Dasari, A.; Meyerhardt, J.; Wolin, E.; Halfdanarson, T.; Chan, J. A. |
Abstract Title: | Efficacy and safety of cabozantinib (CABO) for advanced Grade 3 (G3) neuroendocrine tumours (NETs) after progression on prior therapy: Subgroup analysis of the phase III CABINET trial (Alliance A021602) |
Meeting Title: | 22nd Annual European Neuroendocrine Tumor Society (ENETS) Conference |
Keywords: | cabozantinib; pancreatic neuroendocrine tumour; grade 3 neuroendocrine tumour; extra-pancreatic neuroendocrine tumour |
Journal Title: | Journal of Neuroendocrinology |
Volume: | 37 |
Issue: | Suppl. 1 |
Meeting Dates: | 2025 Mar 5-7 |
Meeting Location: | Krakow, Poland |
ISSN: | 0953-8194 |
Publisher: | Wiley Blackwell |
Date Published: | 2025-03-01 |
Start Page: | e70018 |
Language: | English |
ACCESSION: | WOS:001535097100267 |
PROVIDER: | wos |
DOI: | 10.1111/jne.70018 |
PUBMED: | 40040252 |
Notes: | Meeting Abstract: E48 -- Located on page 205 of the electronic document -- Source: Wos |